ArticleNPJ precision oncology2021

Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target.

Nathan D Seligson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.